News Releases
- September 3, 2020Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report
- September 1, 2020Annovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial
- August 20, 2020Annovis Bio Actively Recruiting Patients for its Phase 2a Trials in Alzheimer’s and Parkinson’s Diseases
- July 23, 2020Annovis Bio CEO Appears on Executive Leaders Radio Program
- July 20, 2020Annovis Bio CEO to Present the Company’s Novel Approach to Treating Parkinson’s Disease at University of Pennsylvania
- July 7, 2020Annovis Bio Receives Institutional Review Board Approval to Initiate 15 Site Phase 2 Study in 68 Parkinson’s and Alzheimer’s Patients
- June 16, 2020Annovis Bio Announces Positive Results from NIH Funded Chronic Toxicology Study
- June 9, 2020Annovis Bio to Present at the June 2020 Virtual Summer Investor Summit
- June 2, 2020Annovis Bio Issued European Patent for Method of Treating Alzheimer’s Disease with ANVS401
- June 1, 2020Annovis Bio 2020 Annual Meeting of Stockholders to Be Held on June 3, 2020
- ,
Media Coverage
Events & Presentations
-
Annovis R&D Day Webcast View Webcast
-
Annovis Corporate Presentation - February 2024
-
AD-PD Conference - March 2022
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top